Debra Weiner

Publications

1. Development and evaluation of a novel knowledge assessment tool for pediatric emergency medicine clerkships. AEM Educ Train. 2024 Feb; 8(1):e10938. View Abstract
2. Pediatric disaster preparedness curriculum across emergency medicine residencies. Am J Disaster Med. 2024 Winter; 19(1):53-58. View Abstract
3. Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective. Am J Hematol. 2023 04; 98(4):620-627. View Abstract
4. Pediatric Casualties in Terrorist Attacks: A Semi-Quantitative Analysis of Global Events. Prehosp Disaster Med. 2023 Feb; 38(1):11-16. View Abstract
5. Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective. Am J Hematol. 2022 11; 97(11):E412-E415. View Abstract
6. Emergency Laboratory Evaluations for Patients With Inborn Errors of Metabolism. Pediatr Emerg Care. 2021 Dec 01; 37(12):e1154-e1159. View Abstract
7. COVID-19 impact on research, lessons learned from COVID-19 research, implications for pediatric research. Pediatr Res. 2020 08; 88(2):148-150. View Abstract
8. Rapid cycle deliberate practice vs. traditional simulation in a resource-limited setting. BMC Med Educ. 2019 Aug 22; 19(1):314. View Abstract
9. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain. Am J Hematol. 2019 06; 94(6):689-696. View Abstract
10. Health care system hazard vulnerability analysis: an assessment of all public hospitals in Abu Dhabi. Disasters. 2014 Apr; 38(2):420-33. View Abstract
11. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies. Clin Trials. 2013 Apr; 10(2):319-31. View Abstract
12. Use of an automated case log to improve trainee evaluations on a pediatric emergency medicine rotation. Pediatr Emerg Care. 2013 Mar; 29(3):314-8. View Abstract
13. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion. 2013 Apr; 53(4):704-9. View Abstract
14. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes. Am J Hematol. 2011 Dec; 86(12):E70-3. View Abstract
15. Response to challenges and lessons learned from Hurricanes Katrina and Rita: a national perspective. Pediatrics. 2011 Aug; 128 Suppl 1:S31-3. View Abstract
16. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain. Pediatr Blood Cancer. 2009 Mar; 52(3):369-72. View Abstract
17. A simulator-based tool that assesses pediatric resident resuscitation competency. Pediatrics. 2008 Mar; 121(3):e597-603. View Abstract
18. FEMA's organized response with a pediatric subspecialty team: the National Disaster Medical System response: a pediatric perspective. Pediatrics. 2006 May; 117(5 Pt 3):S405-11. View Abstract
19. Advanced training in pediatric emergency medicine in the United States, Canada, United Kingdom, and Australia: an international comparison and resources guide. Ann Emerg Med. 2005 Mar; 45(3):269-75. View Abstract
20. Monitoring participant safety in phase I and II interventional trials: options and controversies. J Investig Med. 2004 Nov; 52(7):446-52. View Abstract
21. Hydroxyurea and sickle cell disease: a chance for every patient. JAMA. 2003 Apr 02; 289(13):1692-4. View Abstract
22. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA. 2003 Mar 05; 289(9):1136-42. View Abstract
23. Computerized recruiting for clinical trials in real time. Ann Emerg Med. 2003 Feb; 41(2):242-6. View Abstract
24. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun. 2001 Aug; 69(8):5212-5. View Abstract
25. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr. 2000 Jul; 137(1):73-7. View Abstract
26. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol. 2000 Feb; 35(2):358-62. View Abstract
27. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 1998 Nov; 35 ( Pt 6):745-53. View Abstract
28. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1998 Jun; 31(7):1460-5. View Abstract
29. Comparison of early and late treatment with a recombinant endotoxin neutralizing protein in a rat model of Escherichia coli sepsis. Crit Care Med. 1996 Sep; 24(9):1514-7. View Abstract
30. Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit. Crit Care Med. 1995 Sep; 23(9):1512-8. View Abstract
31. Characterization of tumor-infiltrating lymphocytes from murine mammary adenocarcinomas. Anticancer Res. 1994 May-Jun; 14(3A):881-8. View Abstract
32. Amino acids in amniotic fluid in the second trimester of gestation. Pediatr Res. 1985 Oct; 19(10):1021-4. View Abstract
Show All Publications Show Fewer Publications